Skip to main content
Clinical Proteomics logoLink to Clinical Proteomics
. 2024 May 4;21:31. doi: 10.1186/s12014-024-09484-7

Correction: Kinome and phosphoproteome reprogramming underlies the aberrant immune responses in critically ill COVID-19 patients

Tomonori Kaneko 1, Sally Ezra 1,#, Rober Abdo 2,#, Courtney Voss 1,#, Shanshan Zhong 1, Xuguang Liu 1, Owen Hovey 1, Marat Slessarev 3, Logan Robert Van Nynatten 3, Mingliang Ye 4, Douglas D Fraser 3,5, Shawn Shun‑Cheng Li 1,✉
PMCID: PMC11069263  PMID: 38704547

Correction: Clinical Proteomics (2024) 21:13 10.1186/s12014-024-09457-w

Following publication of the original article [1], the authors identified an error in the author name of Douglas D. Fraser.

The incorrect author name is: Douglas Fraser.

The correct author name is: Douglas D. Fraser.

The author group has been updated above and the original article [1] has been corrected.

Footnotes

Publisher's Note

Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.

Sally Ezra, Rober Abdo and Courtney Voss have contributed equally to this work.

Reference

  • 1.Kaneko T, Ezra S, Abdo R, Voss C, Zhong S, Liu X, Hovey O, Slessarev M, Van Nynatten LR, Ye M, Fraser DD, Li SS-C. Kinome and phosphoproteome reprogramming underlies the aberrant immune responses in critically ill COVID-19 patients. Clin Proteom. 2024;21:13. 10.1186/s12014-024-09457-w. 10.1186/s12014-024-09457-w [DOI] [PMC free article] [PubMed] [Google Scholar]

Articles from Clinical Proteomics are provided here courtesy of BMC

RESOURCES